On August 4, 2022 Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-USA) specialty pharmaceutical company, reported that will release its second quarter 2022 financial results on Thursday, August 11, 2022 prior to market opening (Press release, Knight Therapeutics, AUG 4, 2022, View Source [SID1234617594]). Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!